Pubblicazioni

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe â Methodology and rationale for the multinational observational SANTORINI study

2021 - ATHEROSCLEROSIS PLUS

Ray, Kausik K.; Haq, Inaam; Bilitou, Aikaterini; Aguiar, Carlos; Arca, Marcello; Connolly, Derek L.; Eriksson, Mats; FerriÃ¨res, Jean; Hildebrandt, Per; Laufs, Ulrich; Mostaza, Jose M.; Nanchen, David; Rietzschel, Ernst; Strandberg, Timo; Toplak, Hermann; Visseren, Frank L. J.; Catapano, Alberico L.

Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile

2021 - ATHEROSCLEROSIS PLUS

Lupo, Maria Giovanna; Arcidiacono, Diletta; Zaramella, Alice; Fimiani, Fabio; CalabrÃ², Paolo; CefalÃ¹, Angelo Baldassare; Averna, Maurizio; D'Erasmo, Laura; Arca, Marcello; De Martin, Sara; Zambon, Alberto; Ferri, Nicola

Pubblicazioni

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe â Methodology and rationale for the multinational observational SANTORINI study

Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe â Methodology and rationale for the multinational observational SANTORINI study